Cargando…

Development of curative therapies for sickle cell disease

Recent advances in managing Sickle Cell Disease (SCD) significantly improved patient survival and quality of life. Disease-modifying drug therapies such as hydroxyurea, L-glutamine, voxelotor, and crizanlizumab reduce pain crises and severe complications. Allogeneic hematopoietic stem cell transplan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanhehco, Yvette C., Nathu, Ghazala, Vasovic, Ljiljana V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729691/ https://www.ncbi.nlm.nih.gov/pubmed/36507504 http://dx.doi.org/10.3389/fmed.2022.1055540

Ejemplares similares

Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease
por: Johnson, Kate M., et al.
Publicado: (2022)

Editorial: Developments in sickle cell disease therapy and potentials for gene therapy
por: Maitta, Robert W., et al.
Publicado: (2023)

Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021)

Fighting Post-COVID and ME/CFS – development of curative therapies
por: Scheibenbogen, Carmen, et al.
Publicado: (2023)

Clonal Hematopoiesis and the Risk of Hematologic Malignancies after Curative Therapies for Sickle Cell Disease
por: Gondek, Lukasz P., et al.
Publicado: (2022)

Fertility after Curative Therapy for Sickle Cell Disease: A Comprehensive Review to Guide Care
por: Nickel, Robert Sheppard, et al.
Publicado: (2022)

Debating the Future of Sickle Cell Disease Curative Therapy: Haploidentical Hematopoietic Stem Cell Transplantation vs. Gene Therapy
por: Kassim, Adetola A., et al.
Publicado: (2022)

Glomerular filtration rate abnormalities in sickle cell disease
por: Afangbedji, Nowah, et al.
Publicado: (2022)

Clonal hematopoiesis in sickle cell disease
por: Liggett, L. Alexander, et al.
Publicado: (2022)

The APC-EPCR-PAR1 axis in sickle cell disease
por: Ramadas, Nirupama, et al.
Publicado: (2023)

Whole blood viscosity and red blood cell adhesion: Potential biomarkers for targeted and curative therapies in sickle cell disease
por: Kucukal, Erdem, et al.
Publicado: (2020)

Sickle Cell Disease and Its Respiratory Complications
por: Khan, Mashal I, et al.
Publicado: (2022)

Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease
por: Pavan, Aline Renata, et al.
Publicado: (2022)

Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
por: Serjeant, Graham R.
Publicado: (2021)

Search, identification, and curation of cell and gene therapy product regulations using augmented intelligent systems
por: Schaut, William, et al.
Publicado: (2023)

Allogeneic hematopoietic stem cell transplantation to cure sickle cell disease: A review
por: Bhalla, Nishka, et al.
Publicado: (2023)

Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology
por: Mohanty, Dipika
Publicado: (2022)

Clinical genome editing to treat sickle cell disease—A brief update
por: Zarghamian, Parinaz, et al.
Publicado: (2023)

A Comprehensive Review of Pregnancy in Sickle Cell Disease
por: Shegekar, Tejas, et al.
Publicado: (2023)

Developing an emergency department order set to treat acute pain in sickle cell disease
por: Duroseau, Yves, et al.
Publicado: (2021)

Opioid-Induced Psychosis in a Patient With Sickle Cell Disease
por: Tumenta, Terence, et al.
Publicado: (2021)

Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies
por: Lu, Lu, et al.
Publicado: (2019)

The Role of Non-genetic Therapies to Reduce the Incidence of Sickle Cell Crisis: A Systematic Review
por: Pingili, Shravya, et al.
Publicado: (2023)

Evaluation of Microchip-Based Point-Of-Care Device “Gazelle” for Diagnosis of Sickle Cell Disease in India
por: Shrivas, Shweta, et al.
Publicado: (2021)

Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review
por: Pereira, Laura Resende Guimarães, et al.
Publicado: (2023)

Relationship between paramacular thinning, cerebral vasculopathy, and hematological risk factors in sickle cell disease
por: Orssaud, Christophe, et al.
Publicado: (2023)

Microcytic Anemia: An Insidious Presentation of Sickle Cell Beta+ Thalassemia, a Rare Sickle Cell Variant
por: Shankar, Malavika, et al.
Publicado: (2022)

A Rare Case of Moyamoya Disease in a Patient With Sickle Cell Disease
por: Mohamed, Ayman, et al.
Publicado: (2023)

Long-Term Health Effects of Curative Therapies on Heart, Lungs, and Kidneys for Individuals with Sickle Cell Disease Compared to Those with Hematologic Malignancies
por: Fitzhugh, Courtney D., et al.
Publicado: (2022)

Extracellular Vesicles in Sickle Cell Disease: Plasma Concentration, Blood Cell Types Origin Distribution and Biological Properties
por: Nader, Elie, et al.
Publicado: (2021)

Priming With Red Blood Cells Allows Red Blood Cell Exchange for Sickle Cell Disease in Low-Weight Children
por: Hequet, Olivier, et al.
Publicado: (2021)

Acute Liver Failure in Sickle Cell Disease: A Perfect Storm
por: Burley, Nicholas B, et al.
Publicado: (2021)

The Occurrence of Depression Among Adults With Sickle Cell Disease in Saudi Arabia
por: Sheriff, Muazzam M, et al.
Publicado: (2023)

Low Stroke Risk in Children With Sickle Cell Disease in French Guiana: A Retrospective Cohort Study
por: Gargot, Julie, et al.
Publicado: (2022)

Increased Prevalence of Alloimmunization in Sickle Cell Disease? Should We Restore Blood Donation in French Guiana?
por: Conrath, Salomé, et al.
Publicado: (2021)

The effect of intermittent fasting on the clinical and hematological parameters of patients with sickle cell disease: A preliminary study
por: Ahmed, Khalid, et al.
Publicado: (2023)

Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
por: Alshurafa, Awni, et al.
Publicado: (2022)

Assessment of Reticulocyte and Erythrocyte Parameters From Automated Blood Counts in Vaso-Occlusive Crisis on Sickle Cell Disease
por: Feugray, Guillaume, et al.
Publicado: (2022)

Sickle cell disease chronic joint pain: Clinical assessment based on maladaptive central nervous system plasticity
por: Lopes, Tiago da Silva, et al.
Publicado: (2022)

Sickle Cell Disease Presenting as Extradural Hematoma: An Extremely Rare Fatal Crisis
por: Shah, Divit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3pcabpo3jvfrlr75v5c2k6lk28